Lenalidomide SPC
Lenalidomide SPC is indicated for the treatment of:
Multiple myeloma (MM).
Myelodysplastic syndrome (MDS).
Mantle cell lymphoma (MCL).
Strength:
2.5 mg
5 mg
10 mg
15 mg
20 mg
25 mg
Dosage Form:
Capsule.
Active ingredient:
Lenalidomide.
Pomalidomide SPC
Pomalidomide SPC is indicated for the treatment of Multiple myeloma (MM).
Strength:
1 mg
2 mg
3 mg
4 mg
Dosage Form:
Capsule
Active ingredient:
Pomalidomide.
Bortezomib SPC
Bortezomib SPC is indicated for the treatment of:
Multiple myeloma (MM).
Mantle cell lymphoma (MCL).
Strength:
3.5 mg
Dosage Form:
Vial for injection.
Active ingredient:
Bortezomib.
Carfilzomib SPC
Carfilzomib SPC is indicated for the treatment of Multiple myeloma (MM).
Strength:
60 mg
Dosage Form:
Vial for injection.
Active ingredient:
Carfilzomib.
